Soluble Guanylate Cyclase as a Novel Treatment Target for Osteoporosis

Osteoporosis is a major health problem leading to fractures that cause substantial morbidity and mortality. Current osteoporosis therapies have significant drawbacks, creating a need for novel bone-anabolic agents. We previously showed that the nitric oxide/cyclic GMP (cGMP)/protein kinase G pathway...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Endocrinology
Auteurs principaux: Joshua, Jisha, Schwaerzer, Gerburg K., Kalyanaraman, Hema, Cory, Esther, Sah, Robert L., Li, Mofei, Vaida, Florin, Boss, Gerry R., Pilz, Renate B.
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2014
Sujets:
General Endocrinology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239425/
https://ncbi.nlm.nih.gov/pubmed/25188528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2014-1343
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires